Autopsy report · NCT03494803

Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

“No participants enrolled, leading to insufficient patient numbers to initiate the clinical trial.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

HKGepitherapeutics

Sponsor type

Industry

Conditions

Prostate Cancer; Prostate Adenocarcinoma; Prostate Cancer Metastatic

Participants

0

Sites

1

Countries

Kazakhstan

Trials that died the same way

• Detection of Diffuse Scar in Patients With Diabetes
  “No participants were enrolled in the trial.” (83% match in meaning)
• Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients
  “No patients were enrolled.” (82% match in meaning)
• Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain
  “No patients enrolled in the study.” (81% match in meaning)
• Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
  “No eligible patients were enrolled.” (81% match in meaning)
• A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors
  “leading entity of the clinical trial was replaced, and no patients were enrolled.” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.